Go Pro
Jonathan Yong

Jonathan Yong Analyst Performance

Director at UBS Group

Jonathan Yong is a stock analyst at UBS Group across a range of sectors, covering 4 publicly traded companies. Over the past year, Jonathan Yong has issued 8 stock ratings, including hold and sell recommendations. While full access to Jonathan Yong's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jonathan Yong's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
10 Last 4 Years
Buy Recommendations
10.00% 1 Buy Ratings
Companies Covered
4 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy10.0%1 ratings
Hold70.0%7 ratings
Sell20.0%2 ratings

Out of 10 total stock ratings issued by Jonathan Yong at UBS Group, the majority (70.0%) have been Hold recommendations, followed by 20.0% Sell and 10.0% Buy.

Exchange Coverage

ExchangePercentageCount
NASDAQ
75.0% of companies on NASDAQ
3 companies
NYSE
25.0% of companies on NYSE
1 company

Jonathan Yong, an analyst at UBS Group, currently covers 4 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
2 companies
50.0%
Finance
2 companies
50.0%

Jonathan Yong of UBS Group specializes in stock coverage within the Medical sector, with additional focus on Finance companies.

Coverage Industries

IndustryPercentage
MEDICAL SERVICES
1 company
25.0%
MEDICAL INFO SYS
1 company
25.0%
INS - MULTI LINE
1 company
25.0%
INS - BROKERS
1 company
25.0%

Jonathan Yong's Ratings History at UBS Group

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
7/8/2026Reiterated Rating$20.03Neutral
Clover Health Investments, Corp. stock logo
CLOV
Clover Health Investments
6/11/2026Boost Price Target$4.92$4.75Neutral
Oscar Health, Inc. stock logo
OSCR
Oscar Health
5/7/2026Boost Price Target$19.92$20.00Neutral
Oscar Health, Inc. stock logo
OSCR
Oscar Health
2/11/2026Reiterated Rating$13.55$15.00Neutral
Oscar Health, Inc. stock logo
OSCR
Oscar Health
1/9/2026Upgrade$16.94$17.00Neutral
Oscar Health, Inc. stock logo
OSCR
Oscar Health
11/7/2025Boost Price Target$17.14$12.00Sell
eHealth, Inc. stock logo
EHTH
eHealth
8/7/2025Lower Price Target$3.78$5.00Neutral
Clover Health Investments, Corp. stock logo
CLOV
Clover Health Investments
8/6/2025Lower Price Target$2.22$3.00Neutral
Oscar Health, Inc. stock logo
OSCR
Oscar Health
7/15/2025Reiterated Rating$15.17$11.00Sell